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Abstract: Background: Wilson disease (WD) is characterized by hepatic copper 
accumulation with progressive liver damage to cirrhosis. This study aimed to characterize 
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the toxic milk mouse from The Jackson Laboratory (Bar Harbor, ME, USA) (tx-j) mouse 
model of WD according to changes over time in hepatic copper concentrations, methionine 
metabolism, global DNA methylation, and gene expression from gestational day 17 (fetal) 
to adulthood (28 weeks). Methods: Included liver histology and relevant biochemical 
analyses including hepatic copper quantification, S-adenosylmethionine (SAM) and  
S-adenosylhomocysteine (SAH) liver levels, qPCR for transcript levels of genes relevant to 
methionine metabolism and liver damage, and DNA dot blot for global DNA methylation. 
Results: Hepatic copper was lower in tx-j fetuses but higher in weanling (three weeks) and 
adult tx-j mice compared to controls. S-adenosylhomocysteinase transcript levels were 
significantly lower at all time points, except at three weeks, correlating negatively with 
copper levels and with consequent changes in the SAM:SAH methylation ratio and global 
DNA methylation. Conclusion: Compared to controls, methionine metabolism including  
S-adenosylhomocysteinase gene expression is persistently different in the tx-j mice with 
consequent alterations in global DNA methylation in more advanced stages of liver 
disease. The inhibitory effect of copper accumulation on S-adenosylhomocysteinase 
expression is associated with progressively abnormal methionine metabolism and 
decreased methylation capacity and DNA global methylation. 
Keywords: Wilson disease; copper; DNA; methylation; gene expression 
 
1. Introduction 
Wilson disease (WD) is an autosomal recessive disorder characterized by mutations in the ATP7B 
gene which is responsible for copper (Cu) metabolism and excretion [1], with Cu accumulation in  
liver [2], and brain [3], that leads to progressive liver damage, as well as neurological and psychiatric 
manifestations [4,5]. The toxic milk mouse model of WD from The Jackson Laboratory (tx-j) has a 
G712D missense mutation in the second transmembrane region of ATP7B, which leads to hepatic Cu 
accumulation similar to the disease described in humans [6]. This Cu accumulation in hepatocytes 
results in microvesicular lipid droplets in association with damage to mitochondria [5], nuclei [7], and 
endoplasmic reticulum (ER) [8]. In addition, hepatic Cu accumulation correlates with down-regulation 
of gene transcripts related to lipid metabolism [9] including cholesterol synthesis [10]. 
Previous studies with the tx-j mouse model of WD have shown a progressive accumulation of liver 
Cu over 12 months, along with increases in hepatic apoptotic cells and hepatocyte metallothionein 
levels [11]. Apoptotic cell damage in the first six months of life was associated with increased levels of 
Commd1, a Cu binding protein, while decreased levels of proteins associated with inhibition of 
apoptosis were observed by eight months [4]. Reductions in liver Cu can be achieved in tx-j mice 
using the chelator tetrathiomolybdate [12].  
We have previously demonstrated a close relationship between Cu accumulation and methionine 
metabolism in tx-j mice [9], as others have shown in other animal models of WD [13].  
As shown in Figure 1, methionine metabolism is essential for the production of methyl groups used 
in transmethylation reactions.  
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Figure 1. Methionine metabolism. S-adenosylmethionine (SAM) is the principal methyl 
donor for DNA and histone methylation reactions, whereas S-adenosylhomocysteine 
(SAH) inhibits all SAM-dependent methylation reactions. S-adenosylhomocysteinase 
(AHCY) is the bi-directional enzyme that hydrolyzes SAH to generate homocysteine. 
Methionine synthase (MTR or MS) remethylates homocysteine to form methionine that is 
in turn converted to SAM via the enzyme methionine adenosyltransferase (isoenzymes 
MATI/II/III). Homocysteine can also be remethylated to methionine via the betaine 
homocysteine methyltransferase (BHMT) catalyzed reaction that utilizes betaine. 
Dimethylglycine (DMG) is a byproduct of the BHMT catalyzed reaction and is also a 
potent inhibitor of BHMT. Tetrahydrofolate (THF); DNA methyltransferase (DNMT); histone 
methyltransferase (HMT); glycine N-methyltransferase (GNMT); phosphatidylethanolamine 
N-methyltransferase (PEMT); DNMTs, GNMT, and PEMT are major consumers of SAM 
in the liver [14].  
 
Methionine is an essential amino acid that must be ingested to ensure adequate provisions. In 
addition, methionine is generated from homocysteine via methionine synthase (MS or methionine 
transferase reductase (MTR) and BHMT-catalyzed reactions and is converted into  
S-adenosylmethionine (SAM), the main methyl donor for transmethylation reactions. DNA 
methyltransferases (DNMTs) catalyze DNA methylation reactions with production of  
S-adenosylhomocysteine (SAH). The maintenance of stable and balanced levels of SAM and SAH is 
crucial for cell physiology, as SAM is the main substrate for methylation reactions [15], whereas SAH 
is the major inhibitor for the same reactions. The ratio of SAM:SAH may be considered a relative 
index of methylation capacity [16], which in normal mouse liver tissue has been previously described 
to be in the range of 3 to 4 [14]. SAH regenerates homocysteine through S-adenosylhomocysteinase 
(AHCY), a bidirectional enzyme that favors the generation of SAH if the products homocysteine and 
adenosine are not removed. AHCY can be inhibited by Cu accumulation that results in elevated levels 
of SAH [9,17,18]. We recently associated hepatic Cu accumulation with reduced Ahcy gene expression 
and activity, subsequent elevations of SAH levels, reductions in the SAM: SAH ratio, and reduced 
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DNA methylation. The above were associated with altered expression of genes relevant to liver  
injury [9]. This study also demonstrated that transcript levels of select genes related to methionine 
metabolism are down-regulated in tx-j mice and respond to choline supplementation with restoration 
of gene transcripts to control levels in fetal livers [19]. Others have shown that methionine metabolism 
and the need for methyl groups change over time, with the requirement for methyl groups being 
highest during gestational life [20]. 
In order to study the progression of WD, the present study examined the development of liver 
histology, methionine metabolism, transcript levels of selected genes central to lipid and methionine 
metabolism and global DNA methylation levels in tx-j mice from gestational day 17 (fetal) to postnatal 
week 28 (28 weeks). The study provides new temporal insights into relationships between hepatic Cu 
accumulation and liver damage, altered methionine metabolism, hepatic global DNA methylation, and 
regulation of gene expression. 
2. Results and Discussion 
2.1. Body and Liver Weights, Copper and Iron Status, SAM and SAH Levels, and Liver Histology 
As shown in Table 1, body weights of the tx-j mice were significantly lower at three through  
28 weeks of age than those of controls. Liver weights in the tx-j mice at three and 12 weeks of age 
were lower than those of controls. There was a significant increase in the liver/body weight ratio in the 
tx-j group at 20 and 28 weeks of age that coincided with a worsening of liver histology.  
Liver Cu concentrations in fetal tx-j mice were significantly lower than in controls but by three 
weeks postnatal and thereafter, values were 2–50 times higher than in controls. Liver Cu concentration 
peaked at 20 weeks of age with significant age and genotype interaction (both p < 0.0001) indicating 
that liver Cu concentrations differed significantly over time between the tx-j and control mice. Liver 
iron concentrations in tx-j mice were similar to control levels at most time points, although values in 
the tx-j mice were 1.2 times higher than in controls at 28 weeks. 
Postnatal hepatic SAM levels were higher in tx-j mice than in controls at three weeks with a 
significant interaction of age with genotype (p = 0.01) when examined over all time points. Liver SAH 
levels were similar in both groups at all time points except at three and 12 weeks with an overall 
significant interaction between age and genotype (p < 0.05) over time. The ratio of SAM to SAH 
(SAM:SAH ratio) was significantly lower at 12 weeks in the tx-j mice compared to ratios in the 
controls. When data from all time points were pooled, hepatic Cu concentrations were positively 
correlated with SAH levels (r = 0.44; p = 0.0002) and negatively correlated with SAM:SAH 
methylation ratio (r = −0.43; p = 0.0002) (Figure 2). These findings are compatible with the known 
inhibitory effect of Cu on Ahcy expression and enzymatic activity [9] with a predictive decrease in 
methylation capacity. 
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Table 1. Developmental changes (fetal–28 weeks) in body and liver weights, hepatic copper and iron, and SAM and SAH concentrations. 
Values are expressed as mean ± SD. Values with * are significantly different (p < 0.05) between tx-j vs. control at each time point; ** Copper 
and iron concentrations at the three weeks time points are from livers of 8 controls and 5 tx-j mice; Values with  are significantly different  
(p < 0.05) within the same genotype between 20 and 28 weeks. ND = not determined. Fetal and three weeks data were previously  
published [19]. 
Analysis Fetal 3 weeks 12 weeks 20 weeks 28 weeks 
 Control (n = 8) Tx-j (n = 5) Control (n = 11) Tx-j (n = 10) Control (n = 8) Tx-j (n = 7) Control (n = 9) Tx-j (n = 6) Control (n = 7) Tx-j (n = 7) 
Body weight (g) ND ND 9.29 ± 1.03 7.91 ± 0.84 * 32.3 ± 2.42 27.1 ± 1.45 * 34.8 ± 2.14 28.3 ± 1.10 * 38.7 ± 4.31 32.2 ± 2.58 * 
Liver weight (g) ND ND 0.40 ± 0.060 0.35 ± 0.045 * 1.65 ± 0.12 1.40 ± 0.068 * 1.74 ± 0.14 1.72 ± 0.089 1.84 ± 0.27 1.68 ± 0.27 
Liver/body ratio ND ND 0.043 ± 0.0035 0.044 ± 0.0024 0.051 ± 0.0017 0.052 ± 0.0024 0.050 ± 0.0026 0.061 ± 0.0030 * 0.047 ± 0.0021 0.052 ± 0.0045 * 
Copper (µg/g) ** 7.83 ± 0.72 1.49 ± 0.48 * 12.17 ± 1.72 30.65 ± 7.73 * 5.17 ± 0.99 223.16 ± 52.8 * 7.44 ± 1.84 351 ± 40.5 * 3.86 ± 0.19 190 ± 23.4 *, 
Iron (µg/g) ** 53.34 ± 7.73 48.94 ± 6.08 23.54 ± 3.39 26.16 ± 5.68 68.76 ± 11.54 79.52 ± 35.84 84.60 ± 13.27 91.66 ± 3.42 97.58 ± 14.92 124.07 ± 7.89 *, 
SAM (nmol/g) 105.19 ± 24.83 82.13 ± 14.52 86.97 ± 17.82 122.55 ± 50.37 * 84.9 ± 11.9 76.6 ± 26.3 82.7 ± 17.2 99.9 ± 10.6 74.4 ± 13.2 77.2 ± 7.91 
SAH (nmol/g) 4.04 ± 1.21 4.67 ± 2.88 25.94 ± 8.86 36.55 ± 13.35 * 42.5 ± 10.4 57.2 ± 15.7 * 56.6 ± 26.3 67.7 ± 13.4 28.2 ± 16.8 34.5 ± 11.4 
SAM/SAH ratio 27.59 ± 10.16 23.17 ± 12.77 3.89 ± 1.84 3.39 ± 0.89 2.14 ± 0.69 1.41 ± 0.59 * 1.82 ± 1.13 1.51 ± 0.26 3.76 ± 1.33 2.12 ± 0.52 
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Figure 2. (A) Correlation between hepatic Cu concentration and SAH levels;  
(B) Correlation between hepatic Cu concentration and SAM:SAH levels (using data from 
all time points). 
 
Although there were no changes at 12 weeks, we observed an increase in lymphocyte and PMN 
infiltration and in hepatocyte size in the tx-j group at 20 weeks. At 28 weeks, all the tx-j mice had 
increased hepatocyte sizes with giant nuclei, necrosis, increased lymphocytes, and PMNs. There were 
no histological changes in the control mice at all time points (Figure 3).  
Figure 3. Histology images of tx-j and control livers from three to 28 weeks of age. All 
hematoxylin and eosin stained, 436×. Whereas liver histology was normal in tx-j mice at 
both three and 12 weeks of age (1B and 2B), there was an increase in inflammatory 
infiltrates at 20 and 28 weeks (3B and 4B, thin arrows), in association with giant nuclei and 
markedly increased cell size of the hepatocytes (3B and 4B, thick arrows). Note that in tx-j 
mice hepatocyte cell diameters are 2.5 times and nuclear diameters are about two times 
larger than control mice [19]. Control mice had normal liver histology at all time points 
(1A, 2A, 3A and 4A).  
 
2.2. Transcript Levels of Selected Genes Related to Methionine and Lipid Metabolism 
Transcript levels of 11 different genes were quantified including genes central to lipogenesis, fatty 
acid oxidation, methionine metabolism, and DNA methylation (Figure 4). 
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As previously reported [19], most of the fetal liver genes that were studied were down-regulated in 
the tx-j in comparison to control mice, with the exceptions of Dnmt3a and Mat1a. Subsequently, when 
comparing differences between gene transcript levels in control and tx-j mice at different time points, 
Ahcy was persistently down-regulated in tx-j mice except at three weeks, while Srebf1 and Dnmt3a 
were down-regulated in tx-j mice at 12 weeks. Dnmt1 was up-regulated at 20 weeks and Dnmt3b was  
down-regulated at three and 12 weeks. Both Dnmt3a and Dnmt3b were up-regulated in tx-j mice at  
28 weeks. Mat1a was down-regulated at three weeks but was up-regulated at 12 weeks, and Mat2a 
was up-regulated in tx-j mice at 28 weeks. Mtr was up-regulated in tx-j mice at 12, 20, and 28 weeks. 
When comparing transcript levels in tx-j mice at different ages, transcript levels of almost all genes 
(except for Dnmt3b and Mat1a) were up-regulated at three weeks compared to fetal livers, whereas 
Dnmt3a and Dnmt3b levels were up-regulated at 28 weeks compared to 20 weeks. Consistent with our 
proposed interaction of Cu with methionine metabolism while considering all time points, Ahcy 
transcript levels were negatively correlated with hepatic Cu concentration (r = −0.58; p < 0.0001), and 
hepatic Cu was positively correlated with the expressions of Dnmt1 and Dnmt3a (r = 0.68, p < 0.0001 
and r = 0.28, p = 0.01, respectively). 
Figure 4. Transcript levels of genes related to lipid and methionine metabolism. x-axis: 
time points; y-axis: mean ± SD of relative expression of target genes normalized to Gapdh. 
Values with * are significantly different (p < 0.05) between groups within each time point. 
Values with  are significantly different (p < 0.05) within the same genotype between fetal 
and three weeks. Values with  are significantly different (p < 0.05) within the same 
genotype between 20 and 28 weeks. Genes include Srebf1 (sterol regulatory  
element-binding protein) for lipogenesis, Hspa5 (heat shock protein 5) for ER stress, 
Cpt1A (carnitine palmitoyl transferase 1A) and Pparα (peroxisome proliferator- 
activated receptor α) for fatty acid oxidation, Dnmt1 (DNA methyltransferase 1), Dnmt3a 
(DNA methyltransferase 3a), Dnmt3b (DNA methyltransferase 3b), Ahcy  
(S-adenosylhomocysteinase), Mat1a (methionine adenosyltransferase 1a), Mat2a 
(methionine adenosyltransferase 2a), and Mtr (methionine transferase reductase or 
methionine synthase) for methionine metabolism and DNA methylation. Fetal and three 
weeks data were previously published [19].  
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2.3. Hepatic Global DNA Methylation 
DNA dot blots for global DNA methylation showed that there were no group differences in DNA 
methylation in fetal, three weeks, or 12 weeks old livers between tx-j and control mice. Starting at  
20 weeks of age, tx-j mice DNA showed global hypomethylation compared to control mice with a 
significant interaction with age (p < 0.001), and this pattern persisted at 28 weeks (Figure 5). Pooling 
all time points, global DNA methylation levels were negatively correlated with Dnmt3a and Dnmt3b 
transcript levels (r = −0.26, p = 0.26; r = −0.27, p = 0.01) and were positively correlated with Mat1a 
transcript levels (r = 0.46, p < 0.001).  
Figure 5. Hepatic global DNA methylation. Values with * are significantly different  
(p < 0.05) between tx-j vs. control within each time point. Values are expressed as fold 
change ± SD. Fetal and three weeks data were previously published [19].  
 
In addition, when using data only from 20 and 28 weeks old tx-j and control mice, global DNA 
methylation was negatively correlated with Cu concentrations (r = −0.38; p = 0.049) and SAH levels  
(r = −0.69; p ≤ 0.0001) and positively correlated with SAM:SAH ratio (r = 0.54; p = 0.003) (Figure 6). 
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Figure 6. (A) Correlation between hepatic Cu concentration and global DNA methylation; 
(B) Correlation between SAM:SAH ratio and global DNA methylation (using data from 20 
and 28 week old mice). 
 
The tx-j mice represent a valid model of WD and offer the opportunity to study the relations 
between Cu accumulation and methionine metabolism and their consequences on DNA methylation 
and gene expression. The rationale underlying our study was to describe the temporal relations 
between changes in methionine metabolism, DNA methylation, and gene expression, given that 
epigenetic marks are very dynamic, subject to influences that start during the early development and 
continue throughout life as a consequence of continuous environmental changes. The major findings of 
our study include the following: first that hepatic Cu was significantly lower in fetal livers of tx-j than 
in controls but postnatal values increased significantly over time with a plateau starting at 20 weeks of 
age; in contrast there were only minor differences in liver Fe concentrations. The finding that liver Cu 
concentrations were lower in fetal tx-j than controls may be attributed to the fact that adult tx-j dams 
are characterized by low circulating ceruloplasmin levels, with a putative Cu transport protein [19]. 
The observation that liver Cu concentrations reached a plateau around five months of age has been 
described before in other murine models of hepatic Cu accumulation [21] and may be attributed to 
adaptation mechanisms to hepatic Cu accumulation [4]. Hepatic Fe accumulation, as shown at  
28 weeks, has been described previously in the LEC rat model of WD [22] and it can be speculated 
that this Fe accumulation plays a role in liver damage progression. Kato et al. [22] demonstrated that  
Fe-deficient diet could even prevent the development of fulminant hepatitis in LEC rats. While the 
mechanisms of hepatic Fe accumulation have yet to be elucidated, it is reasonable to speculate that 
since ceruloplasmin can contribute to Fe transport through hepatocyte basolateral membranes, low 
levels of this protein in WD may contribute to hepatic Fe accumulation [23]. Second, whereas almost 
all measured gene transcript levels were down-regulated in the tx-j fetal livers relative to control 
values, low levels of Ahcy persisted throughout all other time points. As a consequence of Ahcy  
down-regulation, the SAM:SAH methylation ratio was lower at 12 weeks of age although not 
consistently at all time points. Similarly, both SAM and SAH did not change consistently over time as 
expected since SAM was increased only at three weeks and SAH was increased only at three and  
12 weeks which may be related to increased Mtr and Mat transcript and activity levels at this time 
points. A previous study reported transcript levels of enzymes related to methionine metabolism and 
mean SAM levels of 112.8 ± 12.4 nmol/g, SAH levels of 25.5 ± 3.9 nmol/g and their ratio of 4.4 ± 0.8 
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in mouse liver tissue [14]. Even though it is difficult to compare different mouse strains and animal 
ages, our SAM and SAH data in fetal livers are comparable with a previous report indicating very low 
SAH levels in fetal livers [24]. However, our present postnatal data are similar to the previous report in 
tx-j and control mice only at three weeks of age, whereas at later time points our SAM:SAH ratio is 
lower (range 1.8–2) due to progressive reduction of SAM levels relative to progressive increase of 
SAH levels. In an unrelated study, untreated C57BL/6J mice had similar SAM:SAH ratio of 2 ± 0.6 at 
five months of age [25]. The effects of Cu levels on methionine metabolism are also emphasized by 
the positive correlation between Cu and SAH levels, and negative correlation between Cu with Ahcy 
transcript levels and the SAM:SAH ratio. Two previous studies in toxic milk mice showed that Ahcy 
has Cu binding properties and its hepatic transcript levels can be reduced up to 42% in association with 
Cu accumulation [17,26]. Interestingly, Bethin et al. showed that Cu deficiency was also associated 
with 45% reduction of Ahcy hepatic levels [26], a finding that is similar to our results in fetal tx-j livers 
and that indicates that Cu metabolism must be strictly regulated to ensure stable Ahcy levels. Others 
showed that Ahcy deficiency in a 26-year-old man was associated with myopathy and developmental 
delay. Electron microscopy of the liver biopsy demonstrated extensive cytoplasmic lipid droplets [27]. 
Mutation of Ahcy in zebrafish was associated with SAH accumulation, increased levels of TNFα, and 
hepatic steatosis [28]. Third, although gene transcript levels were all down-regulated in fetal livers of 
tx-j mice, their improvement to control values after cross-fostering with control dams in all but 
Dnmt3b, Ahcy, and Mat1a at three weeks [19] suggests that maternal milk components may regulate 
hepatic gene expression to control levels. Of note, Ahcy transcript levels were reduced as well in fetal 
livers, similarly to all the other studied genes, despite the fact there was no Cu accumulation.  
We previously hypothesized that fetal hepatocytes in tx-j mice present dysregulation of cell cycle  
that has consequences on gene transcript levels, including Ahcy, and is corrected by methyl groups  
provision [19]. Delgado et al. [13] previously conducted a study on nine-week-old LEC rat models of 
WD, and showed down-regulation of Ahcy transcript levels. Interestingly, their finding of down-regulation 
of Mtr is opposite to present data and they failed to demonstrate any difference in SAM or SAH levels 
compared to wild type rats. These data suggest that various other factors may affect methionine 
metabolites levels. 
Although the gene transcript levels were quite variable over time, global DNA hypomethylation 
was observed at 20 weeks of age and DNA methylation levels correlated negatively with Dnmt3a and 
Dnmt3b and positively with Mat1a transcript levels over all time points. The positive correlation 
between SAM:SAH and global DNA methylation supports the concept that Cu concentrations, 
methionine metabolism, and global DNA methylation can be tightly interrelated with gene expression 
regulation. We confirmed that Ahcy transcript levels were the most affected with consequences on 
SAM:SAH ratio and global DNA hypomethylation at 20 and 28 weeks. In addition, noteworthy, 
hepatic global DNA hypomethylation observed at the later time points was associated with more 
advanced inflammatory infiltrate. The finding of an association of decreased global DNA methylation 
at later time points with inflammatory infiltrates supports our previous results that chronic 
inflammation in WD is associated with an increased demand for methyl groups and consequent global 
DNA hypomethylation [9]. Previous reports suggested that progressive liver disease with early 
indication of fibrosis can be associated with changes in Dnmt levels and global DNA methylation in a 
mouse model of fibrosis induced by carbon tetrachloride [29]. Another study on human liver biopsies 
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from patients with various degrees of severity of liver disease from chronic hepatitis to cirrhosis and 
hepatocellular carcinoma showed a progressive increase transcript levels of Dnmts in association with 
more advanced liver disease [30], an observation that is similar to our current study. In addition, 
previous reports described increased Dnmts transcript levels correlating with reduced global DNA 
methylation likely as a result of a compensatory mechanism [31,32]. The design of our present study 
that is based on timed changes in methionine metabolism and DNA methylation does not allow us to 
determine if DNA methylation is the cause of worsening liver pathology or if it is epiphenomenon or a 
consequence of it. However, it is possible that both hypotheses may be true. As shown by our data, the 
changes in methionine metabolism including down-regulation of Ahcy expression in the fetal liver 
preceded Cu accumulation and inflammation and amplified liver damage, which in turn could increase 
a requirement for methyl groups. Global DNA hypomethylation has consequences on the regulation of 
gene expression as shown in a recent study of progressive liver fibrosis [29]. In addition, improvement 
of global DNA methylation after folate supplementation was associated with decreased inflammation 
in gastric mucosa infected by Helicobacter Pylori [33]. To summarize, our results indicate that the tx-j 
mouse model of WD is characterized by changes in methionine metabolism that are evident from the 
gestational phase of development onwards. Ahcy down-regulation is persistent over time and is 
negatively correlated with increasing hepatic Cu concentration, a finding that is consistent with the 
known inhibitory effects of Cu on its expression [9,26]. As a consequence of Ahcy down-regulation, 
there is a reduction in liver SAM:SAH levels which correlated with global DNA methylation observed 
at the later time points.  
3. Experimental Section  
3.1. Animals and Care 
The study was conducted using C3HeB/FeJ-Atp7btx-J/J (tx-j) mice and C3HeB/FeJ (control) mice. 
All mice were bred in-house on the UC Davis campus (Davis, CA, USA). All animals had access to 
Purina LabDiet 5001 stock (13 µg Cu, 270 µg Fe, 70 µg Zn per g diet, 28% Kcal protein, 12% Kcal 
fat, and 60% Kcal carbohydrate) and deionized water ad libitum. Animals were group-housed in 
polycarbonate cages and maintained according to guidelines set forth by the American Association for 
Accreditation of Laboratory Animal Care IACUC (Institutional Animal Care and Use Committee, UC 
Davis, Davis, CA, USA). The animal room was maintained at 20–23 °C and 45%–65% relative 
humidity with a 14 h light/10 h dark light cycle.  
Dams were anesthetized at gestational day 17 (GD17) via CO2 anesthesia followed by cervical 
dislocation, and fetal livers were pooled and flash-frozen in liquid nitrogen (n = 8 pools of control fetal 
livers; n = 5 pools of tx-j fetal livers). All postnatal tx-j pups were cross-fostered to a lactating control 
dam between post-partum day 0 and 6 due to an insufficient amount of Cu to sustain neonatal 
development and growth in the milk of a tx-j mouse. Mice at 3 (control n = 11; tx-j n = 10), 12 (control 
n = 8; tx-j n = 7), 20 (control n = 9; tx-j n = 6), and 28 (control n = 7; tx-j n = 7) weeks of age were 
euthanized via isoflurane anesthetic followed by exsanguination and cervical dislocation. Sections of 
postnatal livers were placed in formalin or stored in the −80 °C freezer until analysis. Fetal livers and  
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3 weeks livers have been previously published [19]. The protocol was approved by UC Davis IACUC 
(protocol#16172, approved on 21 October 2010). 
3.2. Hepatic SAM and SAH 
Liver levels of SAM and SAH were measured through high-performance liquid chromatography. 
Liver tissue was homogenized in cold 0.5 N perchloric acid at a ratio of 50 mg tissue: 400 µL 
perchloric acid and subsequently centrifuged at 14,000 rpm for 10 min. The supernatant was then 
filtered through a 0.2 µm syringe filter, aliquoted, and stored in the −80 °C freezer until HPLC analysis 
could be performed to quantify SAM and SAH [34]. HPLC analysis was done within 4 weeks of tissue 
collection to ensure sample stability. This method has been confirmed independently in another 
laboratory [35]. 
3.3. Hepatic Copper and Iron 
Approximately 100 mg of liver tissue was digested with concentrated nitric acid and then wet-ashed 
for analysis using flame atomic absorption spectroscopy [36]. 
3.4. Liver Histology 
Liver tissue from both control and tx-j mice were prepared by staining sections with hematoxylin 
and eosin. Images were blind-evaluated for mitosis, nuclei, lymphocytes, PMNs, hepatocyte size,  
and fibrosis. 
3.5. Transcript Levels of Selected Genes by qPCR 
RNeasy Mini Kit (QIAGEN, Valencia, CA, USA) was used to isolate total RNA from liver tissue. 
Purity and concentration of extracted RNA was determined by NanoDrop spectrophotometry  
(Cole-Parmer, IL, USA) and RNA integrity determined by gel electrophoresis. Samples were stored at 
−80 °C until analysis. cDNA was synthesized using the SuperScript III First-Strand cDNA synthesis 
kit (Invitrogen, Carlsbad, CA, USA). SYBR green was used to detect transcript levels of 11 selected 
genes (Table 2); all samples were run in triplicate. Primers for cDNA sequences were designed using 
AB Tm calculator (http://www6.appliedbiosystems.com/support/techtools/calc/index.cfm), NCBI 
Primer-BLAST (http://www.ncbi.nlm.nih.gov/tools/primer-blast/), and Premier Biosoft International 
Beacon Designer (http://www.premierbiosoft.com/qOligo/Oligo.jsp?PID=1). Efficiency of all primers 
was >95% and specificity checked via melt curve and gel electrophoresis. All primers were used at a 
concentration of 300 nM except for Mtr primers which were used at a concentration of 900 nM. qPCR 
was done on the AB ViiA 7 Real-Time PCR System (Applied Biosystem, Foster City, CA, USA). 
Reactions were run at 50 °C for 2 min and 95 °C for 10 min, then 40 cycles at 95 °C for 15 s and  
60 °C for 1 min. All Cq expression values were normalized to Gapdh and relative expression was 
calculated using the equation 2−ΔΔCq, where ΔΔCq = ΔCq (sample) − Cq (calibrator). 
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Table 2. qPCR primer sequences of selected genes. 
Gene Sequence 5' to 3' Accession Position (bp) 
Exon-exon 
overlap 
% Primer 
efficiency 
Srebf1-F CTGGCTTGGTGATGCTATGTTG 
NM_011480.3 
3901–3922 No 
104.9 
Srebf1-R GACCATCAAGGCCCCTCAA 3978–3960 No 
Hspa5-F GTGGAGATCATAGCCAACG 
NM 022310.3 
383–401 No 
102.9 
Hspa5-R CACATACGACGGCGTGATGC 433–414 No 
Cpt1a-F GGAGGAGACAGACACCATCCA 
NM 013495.2 
1044–1064 Yes 
104.1 
Cpt1a-R CGTCATGGTAGAGCCAGACCTT 1138–1117 No 
Pparα-F CGATGCTGTCCTCCTTGATGA 
NM_011144.6 
1401–1421 No 
98.5 
Pparα-R GAAGTCAAACTTGGGTTCCATGAT 1528–1505 No 
Dnmt1-F CCAGCTGCCAAACGGAGA 
NM_001199431.1 
1060–1077 Yes 
102 
Dnmt1-R CCTCGGGAGTCTCTGGAGCTA 1123–1103 No 
Dnmt3a-F CACTGGAGTAGGCGCTGAGAC 
NM_007872.4 
7635–7655 No 
101.6 
Dnmt3a-R CAGCAAAGGGCCTTCCATAG 7699–7680 No 
Dnmt3b-F CCGTTCGACTTGGTGATTGG 
NM_001003961.4 
2352–2371 No 
101.3 
Dnmt3b-R GGGCAGGATTGACGTTAGAGAG 2412–2391 No 
Ahcy-F ATCCTTGGCCGGCACTTT 
NM_016661.3 
949–966 Yes 
97.1 
Ahcy-R TTCTTTAGCCAGTAGCGGTCCA 1100–1079 No 
Mat1a-F TCTGTCCCATACTCACCTCTTCAG 
NM_133653 
1683–1706 No 
98.4 
Mat1a-R TGCCCTGAGGGTAGAAGGC 1771–1753 No 
Mat2a-F CAGGAGACCAGGGTTTGATGTT 
NM_145569 
517–538 Yes 
95.8 
Mat2a-R GCGTAACCAAGGCAATGTACC 653–633 No 
Mtr-F CTGCAGATGTGGCCAGAAAAG 
NM_001081128 
580–600 Yes 
98.9 
Mtr-R CAGCCACAAACCTCTTGACTCC 648–627 No 
3.6. Global DNA Methylation via Dot Blot Analyses 
DNA was isolated from liver samples using the QIAGEN DNeasy Blood & Tissue Kit  
(Valencia, CA, USA). An established method was used to measure relative methylation against  
5-methylcytosine [32]. 50 ng of genomic DNA was alkaline denatured and spotted on a nitrocellulose 
membrane. After UV cross-linking, membranes were blocked in LiCor Odyssey Blocking Buffer 
(LiCor Biosciences, Lincoln, NE, USA), and incubated with anti-5-methylcytosine (Eurogentec, 
Fremont, CA, USA) in Blocking Buffer + 0.1% Tween-20 overnight at 4 °C. Membranes were washed 
in 1× PBS + 0.1% Tween-20, followed by incubation with LiCor 700-IR secondary antibody (LiCor 
Biosciences, Lincoln, NE, USA). Blots were washed again and imaged using the Licor Odyssey 
Imager (LiCor Biosciences, Lincoln, NE, USA). Blots were rinsed with 2× SSC buffer then 
equilibrated in PerfectHyb Plus Hybridization Buffer (Sigma, St. Louis, MO, USA) at 42 °C. Blots 
were hybridized with heat-denatured biotin-labeled gDNA overnight at 42 °C, washed with a high 
stringency buffer, then blocked again with Blocking Buffer. Blots were further incubated with LiCor 
Streptavidin 800-IR secondary antibody (LiCor Biosciences, Lincoln, NE, USA) in Blocking Buffer + 
0.1% Tween-20 for 1 h at room temperature, then imaged on the LiCor Odyssey Imager (LiCor 
Biosciences, Lincoln, NE, USA). LiCor Odyssey software (LiCor Biosciences, Lincoln, NE, USA) 
was used to analyze the integrated intensities. Methylation signal was normalized to the total DNA 
signal [9] and results expressed as fold change relative to the control group for each time point. 
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3.7. Statistical Analysis 
Statistical analysis was performed using a two-way ANOVA with an interaction term. Where the 
overall ANOVA was significant, we identified genotypes (tx-j vs. control) and cross-sectional time 
points (fetal and 3, 12, 20, or 28 weeks of age) that differed significantly using Tukey’s multiple 
comparison procedure and maintained the family-wise error rate at 0.05. Pearson correlation 
coefficient and its p-value for significance of correlation were calculated to assess the magnitude and 
direction of an association between two given variables. For data that were highly skewed, we applied 
a natural log transformation to achieve normality prior to statistical analysis and significance testing 
was done on a log-transformed scale. All reported p-values are based on two-sided tests. A p-value 
<0.05 was considered significant. All statistical analyses were performed using SAS, Version 9.4  
(SAS Institute, Cary, NC, USA). 
4. Conclusions 
In the present study, we observed that transcript levels of genes related to methionine metabolism 
are aberrant in the liver of the tx-j mouse model of WD from late gestation to adult life in parallel with 
increasing levels of hepatic Cu and abnormal histopathology. The accumulation of hepatic Cu 
correlated with decreasing expression of Ahcy, with consequent increases in SAH levels and reduction 
in SAM:SAH methylation ratios at several time points. In more advanced phases of liver disease, tx-j 
mice presented global DNA hypomethylation which in turn correlated with the SAM:SAH ratio. The 
interaction between Cu accumulation and methionine metabolism is a crucial mechanism of disease 
onset and progression in WD indicating that there is a close connection between genetic and epigenetic 
mechanisms that ultimately determinates the phenotypic expression of this condition. 
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